Table 2.
Inoculation with different strains and its effect on nodule occupancy evaluated by the immuno-agglutination and MALDI-TOF MS methods (means of 4 repetitions ± standard deviation)
| Inoculated strain | Nodular occupation 6th year (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Immuno-agglutination | MALDI-TOF MS | ||||||||
| 1st year | 2nd year on | SEMIA 5080 | SEMIA 5079 | SEMIA 587 | SEMIA 5019 | SEMIA 5080 | SEMIA 5079 | SEMIA 587 | SEMIA 5019 |
| SEMIA 5080 | SEMIA 5080 | 52 ± 12 | 18 ± 14 | 22 ± 6 | 7 ± 6 | 33 ± 2 | 43 ± 7 | 21 ± 2 | 3 ± 1 |
| SEMIA 5080 | Non-inoculated | 35 ± 12 | 36 ± 25 | 20 ± 6 | 9 ± 7 | 0 ± 0 | 45 ± 3 | 55 ± 6 | 0 ± 0 |
| SEMIA 5080 | SEMIA 5079 | 11 ± 6 | 61 ± 2 | 16 ± 9 | 12 ± 8 | 0 ± 0 | 74 ± 4 | 20 ± 2 | 6 ± 1 |
| SEMIA 5079 | SEMIA 5079 | 12 ± 3 | 62 ± 7 | 18 ± 8 | 8 ± 3 | 0 ± 0 | 95 ± 8 | 5 ± 2 | 0 ± 0 |
| SEMIA 5079 | Non-inoculated | 27 ± 4 | 46 ± 5 | 15 ± 8 | 12 ± 4 | 0 ± 0 | 86 ± 5 | 14 ± 3 | 0 ± 0 |
| SEMIA 5079 | SEMIA 5080 | 55 ± 7 | 15 ± 8 | 26 ± 7 | 4 ± 2 | 41 ± 3 | 18 ± 2 | 41 ± 2 | 0 ± 0 |